Modus Therapeutics funding - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image illustrating rising takeover speculation around Papa John’s International, Inc., as renewed private equity interest and a reported $65-per-share bid from TriArtisan Capital Advisors push the PZZA stock back into focus amid ongoing turnaround efforts.

Papa John’s agrees to explore sale as renewed private equity interest lifts PZZA

Could Turtle Pond discoveries extend the geological story behind Kenbridge nickel? (CSE: TN)

Vision Marine Technologies expands electric boating strategy through pontoon segment leadership and SPECTR 26 launch

Vision Marine (NASDAQ: VMAR) targets pontoon dominance with SPECTR 26 electric platform strategy

Why Canuc Resources Corporation is quietly expanding its Sudbury exploration corridor (TSXV: CDA)

Read More

2 minute read

Pharma Industry News

Modus Therapeutics secures $15.7m for sickle cell disease drug development

Modus Therapeutics, a Swedish biotech firm specializing in sickle cell disease therapies, has successfully raised SEK 140 million…

bypharmanewsdaily

July 15, 2018

web analytics